Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Primary cardiac lymphoma presenting with atrioventricular block.
|
Korean Circ J
|
2010
|
1.14
|
2
|
Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.
|
Cancer Chemother Pharmacol
|
2007
|
1.11
|
3
|
Multiple gastrointestinal stromal tumors with a germline c-kit mutation.
|
Pathol Int
|
2005
|
0.97
|
4
|
Korean patients with superwarfarin intoxication and their outcome.
|
J Korean Med Sci
|
2010
|
0.91
|
5
|
Phase II trial of combination chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced cancers of the bile duct, gallbladder, and ampulla of Vater.
|
Tumori
|
2013
|
0.82
|
6
|
Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP.
|
Cancer Chemother Pharmacol
|
2007
|
0.82
|
7
|
A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesics.
|
Support Care Cancer
|
2013
|
0.80
|
8
|
actate Dehydrogenase (LDH) as a Tumor Marker for Non-small Cell Lung Cancer.
|
Cancer Res Treat
|
2002
|
0.80
|
9
|
[A phase II study of combination chemotherapy with gemcitabine, 5-fluorouracil, and cisplatin for advanced pancreatic cancer].
|
Korean J Gastroenterol
|
2005
|
0.76
|
10
|
A phase II trial of 5-fluorouracil, leucovorin and mitomycin C in patients with advanced gastric cancer.
|
Tumori
|
2012
|
0.76
|
11
|
A case of invasive thymoma with endotracheal polypoid growth.
|
Tuberc Respir Dis (Seoul)
|
2012
|
0.75
|
12
|
A phase II trial of paclitaxel, 5-fluorouracil (5-FU) and cisplatin in patients with metastatic or recurrent gastric cancer.
|
Cancer Res Treat
|
2008
|
0.75
|
13
|
A phase II study of vinorelbine, mitomycin C and cisplatin chemotherapy for advanced non-small cell lung cancer.
|
Korean J Intern Med
|
2002
|
0.75
|